Surgery Websites
Vascular & Endovascular Surgery »  Meet the Team »  Vascular Surgeons »  Peter A. Schneider, M.D.
Peter A. Schneider, M.D.

Peter A. Schneider, M.D.

Professor of Surgery
Division of Vascular & Endovascular Surgery

Contact Information

Division of Vascular and Endovascular Surgery
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
peter.schneider@ucsf.edu
Open Popup

The Johns Hopkins University School of Medicine Five-Year BA-MD Curriculum, The Johns Hopkins University, Baltimore, MD, Class of 1983

Undergraduate, University of California San Diego, La Jolla, CA, 1976-1978



  • University of California San Francisco, San Francisco, CA
  • Resident in General Surgery, June, 1983 to June, 1986 and July, 1988 to June, 1989
  • Chief Resident in General Surgery, July, 1989 to June, 1990
  • Research Fellowship: Roon Center of Arteriosclerosis and Thrombosis, Department of Basic Research and Noninvasive Vascular Diagnostic Laboratory, Scripps Clinic and Research Foundation, La Jolla, CA, July, 1986 to June, 1988
  • Clinical Fellowship: University of California San Francisco, San Francisco, CA, Clinical Fellow in Vascular Surgery, July, 1990 to June, 1991
  • American Board of Surgery, Vascular Surgery

Peter A. Schneider, M.D. is Professor of Surgery in the Division of Vascular & Endovascular Surgery at University of California San Francisco. Dr. Schneider received his MD from the Johns Hopkins School of Medicine and completed his general surgery residency and vascular surgery fellowship at the University of California San Francisco.

Dr. Schneider was the founding member and chief of the Division of Vascular Surgery at Kaiser Permanente in Hawaii from 1994-2018. At Kaiser, he developed an aneurysm screening and surveillance program for patients with aneurysms and a registry for patients with carotid disease used for surveillance. He oversaw the development of the first endovascular operating room in the Kaiser system.

Dr. Schneider has served on numerous committees for the Society for Vascular Surgery and is the past president of Western Vascular Society where he also served on a number of its committees. He has been invited to numerous visiting professorships and has served as faculty or course director for many specialty courses. He authored "Endovascular Skills," the 4th edition, to be published in 2019, and has co-authored three other books on various aspects of vascular surgery. Dr. Schneider founded two medical device companies, served as an adviser to many others, and has been awarded numerous patents.

Dr. Schneider is a Fellow of the American College of Surgeons, Distinguished Fellow of the Society for Vascular Surgery, Fellow of the International Society of Vascular Surgery, a past president of Western Vascular Society and has authored several textbooks including Endovascular Skills, the 4th edition, to be published later this year. During the course of his career, Dr. Schneider has published more than 100 articles in peer-reviewed journals.

Dr. Schneider has served as National Principal Investigator for numerous clinical trials. Over 25 years, he has been a strong proponent of clinical research in vascular disease and has participated extensively in trial design, oversight, core lab analysis, events committees, data analysis, follow up, presentation, and publication. He has consulted on the regulatory pathway and pivotal trials for many vascular devices, has participated in numerous meetings with the FDA and has testified at FDA panel hearings. His experience includes performing procedures for several first-in-human trials. 

MOST RECENT PUBLICATIONS FROM A TOTAL OF 85
Data provided by UCSF Profiles, powered by CTSI
  1. Kim TI, Vartanian SS, Schneider PA. A Review and Proposed Classification System for the No-Option Patient With Chronic Limb-Threatening Ischemia. J Endovasc Ther. 2020 Oct 09; 1526602820963911. View in PubMed
  2. Longo M, Harrison J, Valentine H, Nikanorov A, Horzewski M, Teigen N, Schneider PA. Effects of external crushing forces on a novel below-the-knee vascular implant. J Cardiovasc Surg (Torino). 2020 Sep 14. View in PubMed
  3. Schneider PA, Varcoe RL, Secemsky E, Schermerhorn M, Holden A. Update on paclitaxel for femoral-popliteal occlusive disease in the 15 months following a summary level meta-analysis demonstrated increased risk of late mortality and dose response to paclitaxel. J Vasc Surg. 2020 Sep 02. View in PubMed
  4. Schneider PA, Brodmann M, Mauri L, Laird J, Soga Y, Micari A, Ansel G, Shishehbor MH, Krishnan P, Gao Q, Ouriel K, Zeller T. Paclitaxel exposure: Long-term safety and effectiveness of a drug-coated balloon for claudication in pooled randomized trials. Catheter Cardiovasc Interv. 2020 Aug 24. View in PubMed
  5. Kashyap VS, Schneider PA, Foteh M, Motaganahalli R, Shah R, Eckstein HH, Henao S, LaMuraglia G, Stoner MC, Melton J, Massop D, Hanover T, Titus J, Moore WS, Rodríguez-Carvajal R, Malas MB, Arko FR, Pierce D, Anain P, Oskin T. Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in Patients With Significant Carotid Artery Disease. Stroke. 2020 Sep; 51(9):2620-2629. View in PubMed
  6. View All Publications

 

Site Directory
    X